来自官方财务报表的收入、利润与现金流历史。
Align Technology, Inc. 在美国、瑞士和国际上提供 Invisalign 隐形矫正器、Vivera 保持器和 iTero 口内扫描仪及服务。该公司的 Clear Aligner 部门提供 Invisalign 隐适美综合方案，用于治疗成人和青少年的咬合不正和特征，以及青少年或更年轻患者的正畸需求； Invisalign First 第一阶段和 Invisalign First 综合第二阶段套餐适用于 6 至 10 岁的年轻患者，其中包括乳牙/婴儿牙和恒牙。该细分市场还提供 Invisalign 隐适美 Express、Invisalign lite 和 Invisalign 中度隐适美； Invisalign Go、Invisalign Go express 和 Invisalign Go Plus；固位产品、Invisalign 隐适美培训、牙科专业人员在治疗期间使用的调整工具、辅助 Invisalign 隐适美配件产品以及其他口腔保健产品； Invisalign 隐适美专业美白系统； Invisalign 隐适美腭扩张器，一种 3D 打印的正畸装置；和 3D 打印解决方案。
机器翻译
| 利润表 | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 总收入 | $4.1B | $4.0B | $4.0B | $3.9B | $3.7B | $4.0B | $2.5B | $2.4B | $2.0B | $1.5B | $1.1B | $845M | $762M | $660M | $560M | $480M | $387M | $312M | $304M | $284M | $206M |
| 毛利 | $2.8B | $2.8B | $2.8B | $2.7B | $2.6B | $2.9B | $1.8B | $1.7B | $1.4B | $1.1B | $815M | $640M | $578M | $498M | $416M | $361M | $303M | $233M | $225M | $209M | $142M |
| 毛利率% | 67.7% | 68.3% | 70.0% | 70.1% | 70.5% | 74.3% | 71.3% | 72.5% | 73.6% | 75.8% | 75.5% | 75.7% | 75.9% | 75.4% | 74.4% | 75.3% | 78.4% | 74.8% | 74.1% | 73.6% | 68.6% |
| 营业利润（EBIT） | $592M | $616M | $608M | $643M | $643M | $976M | $387M | $542M | $467M | $354M | $249M | $189M | $194M | $94M | $86M | $90M | $103M | ($34M) | $16M | $34M | ($38M) |
| 营业利润率% | 14.4% | 15.3% | 15.2% | 16.7% | 17.2% | 24.7% | 15.7% | 22.5% | 23.7% | 24.0% | 23.1% | 22.3% | 25.4% | 14.3% | 15.3% | 18.8% | 26.5% | -10.9% | 5.1% | 11.9% | -18.2% |
| 净利 | $430M | $410M | $421M | $445M | $362M | $772M | $1.8B | $443M | $400M | $231M | $190M | $144M | $146M | $64M | $59M | $67M | $74M | ($31M) | $80M | $36M | ($35M) |
| 净利润率 % | 10.5% | 10.2% | 10.5% | 11.5% | 9.7% | 19.5% | 71.8% | 18.4% | 20.3% | 15.7% | 17.6% | 17.0% | 19.1% | 9.7% | 10.5% | 13.9% | 19.2% | -10.0% | 26.3% | 12.6% | -16.9% |
| EBITDA | $910M | $766M | $817M | $643M | $780M | $1.1B | $481M | $593M | $521M | $391M | $273M | $207M | $211M | $178M | $140M | $108M | $121M | ($21M) | $30M | $47M | ($27M) |
| 每股收益（EPS） | $5.97 | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 | $22.41 | $5.53 | $4.92 | $2.83 | $2.33 | $1.77 | $1.77 | $0.78 | $0.71 | $0.83 | $0.95 | $-0.45 | $1.18 | $0.50 | $-0.55 |
| 已发行股数 (M) | 72M | 73M | 75M | 77M | 78M | 80M | 79M | 80M | 81M | 82M | 81M | 82M | 82M | 83M | 83M | 80M | 78M | 69M | 68M | 71M | 63M |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 ALGN 交互式查看器。 /companies/us/ALGN
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms